The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment

Yin, Shengxia; Wan, Yawen; Issa, Rahma; Zhu, Yijia; Xu, Xiaoming; Liu, Jiacheng; Mao, Minxin; Li, Ming; Tong, Xin; Tian, Chen; Wang, Jian; Huang, Rui; Zhang, Qun; Wu, Chao; Chen, Yuxin; Li, Jie

Published in

Taylor and Francis Group, Emerging Microbes and Infections, 2(12), 2023

DOI: 10.1080/22221751.2023.2259003

Tools

Export citation

Search in Google Scholar

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment

Journal article published in 2023 by Shengxia Yin, Yawen Wan, Rahma Issa, Yijia Zhu, Xiaoming Xu, Jiacheng Liu, Minxin Mao, Ming Li, Xin Tong, Chen Tian, Jian Wang, Rui Huang, Qun Zhang, Chao Wu, Yuxin Chen and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving allowed

Upload

Policy details

Data provided by

Published in

Links

Tools

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment